Visualizing cancer and immune cell function with metabolic positron emission tomography

Rachel E. Laing, Evan Nair-Gill, Owen N. Witte, Caius G. Radu

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Cancer cells and immune cells modulate their metabolism according to specific needs during cancer progression and immune responses. The ability to measure cellular metabolic function in vivo would enable the evaluation of tumors and their response to therapy and also the effectiveness of cellular immune responses to cancer. Positron emission tomography (PET) is a highly sensitive clinical imaging modality that enables whole-body, quantitative measurements of tissue biochemical function. Here, we review work using PET probes for specific metabolic pathways to measure cell function in cancer and immunity. We focus on the use of probes for glycolysis and nucleoside salvage and then discuss the development of new metabolic probes that visualize distinct parameters of cell function during disease.

Original languageEnglish (US)
Pages (from-to)100-105
Number of pages6
JournalCurrent Opinion in Genetics and Development
Volume20
Issue number1
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Neoplasms
Glycolysis
Metabolic Networks and Pathways
Nucleosides
Cellular Immunity
Immunity
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Visualizing cancer and immune cell function with metabolic positron emission tomography. / Laing, Rachel E.; Nair-Gill, Evan; Witte, Owen N.; Radu, Caius G.

In: Current Opinion in Genetics and Development, Vol. 20, No. 1, 01.02.2010, p. 100-105.

Research output: Contribution to journalReview article

@article{ba0dca41629345938571e698ec4a362e,
title = "Visualizing cancer and immune cell function with metabolic positron emission tomography",
abstract = "Cancer cells and immune cells modulate their metabolism according to specific needs during cancer progression and immune responses. The ability to measure cellular metabolic function in vivo would enable the evaluation of tumors and their response to therapy and also the effectiveness of cellular immune responses to cancer. Positron emission tomography (PET) is a highly sensitive clinical imaging modality that enables whole-body, quantitative measurements of tissue biochemical function. Here, we review work using PET probes for specific metabolic pathways to measure cell function in cancer and immunity. We focus on the use of probes for glycolysis and nucleoside salvage and then discuss the development of new metabolic probes that visualize distinct parameters of cell function during disease.",
author = "Laing, {Rachel E.} and Evan Nair-Gill and Witte, {Owen N.} and Radu, {Caius G.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.gde.2009.10.008",
language = "English (US)",
volume = "20",
pages = "100--105",
journal = "Current Opinion in Genetics and Development",
issn = "0959-437X",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Visualizing cancer and immune cell function with metabolic positron emission tomography

AU - Laing, Rachel E.

AU - Nair-Gill, Evan

AU - Witte, Owen N.

AU - Radu, Caius G.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Cancer cells and immune cells modulate their metabolism according to specific needs during cancer progression and immune responses. The ability to measure cellular metabolic function in vivo would enable the evaluation of tumors and their response to therapy and also the effectiveness of cellular immune responses to cancer. Positron emission tomography (PET) is a highly sensitive clinical imaging modality that enables whole-body, quantitative measurements of tissue biochemical function. Here, we review work using PET probes for specific metabolic pathways to measure cell function in cancer and immunity. We focus on the use of probes for glycolysis and nucleoside salvage and then discuss the development of new metabolic probes that visualize distinct parameters of cell function during disease.

AB - Cancer cells and immune cells modulate their metabolism according to specific needs during cancer progression and immune responses. The ability to measure cellular metabolic function in vivo would enable the evaluation of tumors and their response to therapy and also the effectiveness of cellular immune responses to cancer. Positron emission tomography (PET) is a highly sensitive clinical imaging modality that enables whole-body, quantitative measurements of tissue biochemical function. Here, we review work using PET probes for specific metabolic pathways to measure cell function in cancer and immunity. We focus on the use of probes for glycolysis and nucleoside salvage and then discuss the development of new metabolic probes that visualize distinct parameters of cell function during disease.

UR - http://www.scopus.com/inward/record.url?scp=75849151738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75849151738&partnerID=8YFLogxK

U2 - 10.1016/j.gde.2009.10.008

DO - 10.1016/j.gde.2009.10.008

M3 - Review article

C2 - 19931447

AN - SCOPUS:75849151738

VL - 20

SP - 100

EP - 105

JO - Current Opinion in Genetics and Development

JF - Current Opinion in Genetics and Development

SN - 0959-437X

IS - 1

ER -